Tag: <span>Goldilocks drug</span>

Home / Goldilocks drug
Researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer
Post

Researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer

by Mikayla Mace Kelley, University of Arizona cSNX1.3 competitively inhibits binding of EGFR to SNX1. A Ribbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZS). The proposed SNX1 binding site is well away from the kinase active site. B SDS page gels for purified SNX1 Bar domain (residues 301–522) and EGFR kinase...